Methods and Systems for Analysis of Chromatin
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application PCT/US2019/017723, filed Feb 12, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,725,027 | Methods and Systems for Analysis of Chromatin In force · Medium confidence | 10X Genomics, Inc. | In force | Medium confidence | ||
| US 10,816,543 | Methods and Systems for Analysis of Major Histocompatability Complex In force · Medium confidence | 10X Genomics, Inc. | In force | Medium confidence | ||
| US 10,928,386 | Methods and Systems for Characterizing Multiple Analytes from Individual Cells or Cell Populations In force · Medium confidence | 10X Genomics, Inc. | In force | Medium confidence | ||
| US 11,002,731 | Methods and Systems for Antigen Screening In force · Low confidence | 10X Genomics, Inc. | In force | Low confidence | ||
| US 11,131,664 | Methods and Systems for Macromolecule Labeling In force · Low confidence | 10X Genomics, Inc. | In force | Low confidence | ||
| US 11,255,847 | Methods and Systems for Analysis of Cell Lineage In force · Medium confidence | 10X Genomics, Inc. | In force | Medium confidence | ||
| US 11,739,440 | Methods and Systems for Analysis of Chromatin In force · Medium confidence | 10X Genomics, Inc. | In force | Medium confidence | ||
| US 12,049,712 | Methods and Systems for Analysis of Chromatin In force · Medium confidence | 10X Genomics, Inc. | In force | Medium confidence | ||
| Application 17/209,045 | Methods and Systems for Antigen Screening Abandoned Abandoned Dec 16, 2023 | 10X Genomics, Inc. | Abandoned | Abandoned Dec 16, 2023 | ||
| Application 18/742,590 | Methods and Systems for Analysis of Chromatin Pending Not granted | 10X Genomics, Inc. | Pending | Not granted |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
8 of these are in force and held by 10X Genomics, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.